Market Research Logo

US Market Report for Mechanical Thrombectomy Devices 2017 - MedCore

US Market Report for Mechanical Thrombectomy Devices 2017 - MedCore

There will be significant market growth in the mechanical thrombectomy market over the forecast period, driven by growth in unit sales as mechanical thrombectomy is adopted as standard of care for acute ischemic stroke patients. This market includes stent retrievers and suction thrombectomy catheters. The majority of the time a combination of the two categories is used but there a number of factors that can impact treatment decisions, one key factor being physician preference. Studies found new stent retriever devices are superior to first generation aspiration devices but there have been fewer studies comparing the second generation of both categories. Prior to 2012 it was mainly aspiration used and then with the entrance of stent retrievers, they became the primary treatment. In the last year or so, combination therapy has become the most common. Both categories of devices have a role as certain devices appear to more successful based on the anatomy, clot morphology and clot locations. Additional clinical trials will influence whether the devices continue to be used in conjunction or whether one category will cannibalize shares form the other.

Ischemic Stroke is caused by an obstruction within a blood vessel that is supplying blood to the brain. This is often caused by blood clots but can also be caused by other substances like plaque. The gold standard treatment for strokes for many years has been the administration of clot dissolving or clot busting medication called tissue plasminogen activator (tPA). This type of drug must be administered as soon as possible, with a four hour window from symptom onset, to increase chances of recovery. A significant number of patients do not get to healthcare facilities quickly enough to meet that window and even some of those who do, later experience hemorrhagic complications from the medication. It is very effective for smaller clots but often fails to break up larger clots. Some patients cannot receive tPA, in which cases physicians rely on antiplatelet or anticoagulant medicine to ensure blood clots do not get larger.


EXECUTIVE SUMMARY
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics and Neurosurgery
2.2.3 Tumor and Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication for Neuromodulation
2.2.9 Traumatic brain injury
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Mechanical Thrombectomy
3.1.1.1 Introduction
3.1.1.2 Product Matrix for Mechanical Trombectomy device: Core Companies
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Mechanical Thrombectomy
3.3 CLINICAL TRIALS
3.3.1 Mechanical Thrombectomy
MECHANICAL THROMBECTOMY MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Stent Retrievers
4.3.2 Thrombectomy Catheters
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023
Chart 4 1: Mechanical Thrombectomy Market by Segment, U.S., 2013 – 2023
Chart 4 2: Mechanical Thrombectomy Market Breakdown, U.S., 2016
Chart 4 3: Mechanical Thrombectomy Market Breakdown, U.S., 2023
Chart 4 4: Stent Retriever Market, U.S., 2013 – 2023
Chart 4 5: Thrombectomy Catheter Market, U.S., 2013 – 2023
Chart 4 6: Leading Competitors, Mechanical Thrombectomy Market, U.S., 2016
List of Figures
Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2016
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016
Figure 1 9: Neurological Device Markets Covered, U.S., 2016
Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2)
Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2)
Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 14: Key Report Updates
Figure 1 15: Version History
Figure 2 1: Neurology Disease Overview
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Class 2 Device Recall: Trevo Pro 4 Stent Retriever
Figure 3 2: Mechanical Trombectomy: Comparison of Thrombectomy and Standard Care for Ischemic Stroke
Figure 3 3: Mechanical Trombectomy: Interest of Direct Aspiration First Pass Technique (ADAPT)
Figure 3 4: Mechanical Trombectomy: Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy
Figure 3 5: Mechanical Trombectomy: Evaluation of the ReVive SE Device for Intra-Arterial Thrombectomy in Acute Ischemic Stroke
Figure 3 6: Mechanical Trombectomy: Trial and Cost Effectiveness Evaluation of Intra-arterial Thrombectomy
Figure 4 1: Mechanical Thrombectomy Market by Segment, U.S., 2013 – 2023
Figure 4 2: Stent Retriever Market, U.S., 2013 – 2023
Figure 4 3: Thrombectomy Catheter Market, U.S., 2013 – 2023
Figure 4 4: Drivers and Limiters, Mechanical Thrombectomy Market, U.S., 2016
Figure 4 5: Leading Competitors, Mechanical Thrombectomy Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report